LIFE SCIENCES HOLDINGS FRANCE SAS : revenue, balance sheet and financial ratios

LIFE SCIENCES HOLDINGS FRANCE SAS is a French company founded 25 years ago, specialized in the sector Réparation de matériels électroniques et optiques. Based in SAINT-GERMAIN-EN-LAYE (78100), this company of category ETI shows in 2024 a revenue of 22.9 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - LIFE SCIENCES HOLDINGS FRANCE SAS (SIREN 433819455)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue 22 874 720 € 22 529 583 € 19 882 968 € 20 765 629 € 15 497 355 € 14 568 507 € 18 003 145 € 14 896 697 € 16 006 683 €
Net income -8 091 908 € 58 879 647 € 84 199 179 € 192 857 382 € -28 298 063 € 39 800 652 € 46 621 797 € 124 435 230 € 142 655 601 €
EBITDA -226 854 € 1 069 278 € -285 461 € 669 139 € 22 330 € -265 340 € 3 408 626 € -3 738 200 € 103 493 €
Net margin -35.4% 261.3% 423.5% 928.7% -182.6% 273.2% 259.0% 835.3% 891.2%

Revenue and income statement

In 2024, LIFE SCIENCES HOLDINGS FRANCE SAS achieves revenue of 22.9 M€. Revenue is growing positively over 9 years (CAGR: +4.6%). Vs 2023: +2%. After deducting consumption (5.2 M€), gross margin stands at 17.7 M€, i.e. a rate of 77%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -227 k€, representing -1.0% of revenue. Warning negative scissor effect: despite revenue change (+2%), EBITDA varies by -121%, reducing margin by 5.7 pts. This reflects costs rising faster than revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Net income is negative at -8.1 M€ (-35.4% of revenue), which will impact equity.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

22 874 720 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

17 690 843 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-226 854 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

1 004 153 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-8 091 908 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

-1.0%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 13%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 88%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

13.222%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

88.22%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

-69.808%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

-41.428

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

3.2%

Solvency indicators evolution
LIFE SCIENCES HOLDINGS FRANCE SAS

Sector positioning

Debt ratio
13.22 2024
2022
2023
2024
Q1: 0.05
Med: 9.93
Q3: 29.51
Average

In 2024, the debt ratio of LIFE SCIENCES HOLDINGS FR... (13.22) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
88.22% 2024
2022
2023
2024
Q1: 26.48%
Med: 50.0%
Q3: 62.83%
Excellent +11 pts over 3 years

In 2024, the financial autonomy of LIFE SCIENCES HOLDINGS FR... (88.2%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
-41.43 years 2024
2022
2023
2024
Q1: 0.0 years
Med: 0.0 years
Q3: 0.88 years
Excellent -76 pts over 3 years

In 2024, the repayment capacity of LIFE SCIENCES HOLDINGS FR... (-41.43) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 1088.99. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

1088.989

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-12972.711

Liquidity indicators evolution
LIFE SCIENCES HOLDINGS FRANCE SAS

Sector positioning

Liquidity ratio
1088.99 2024
2022
2023
2024
Q1: 189.26
Med: 248.71
Q3: 335.97
Excellent -8 pts over 3 years

In 2024, the liquidity ratio of LIFE SCIENCES HOLDINGS FR... (1088.99) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
-12972.71x 2024
2022
2023
2024
Q1: 0.0x
Med: 0.09x
Q3: 2.24x
Watch

In 2024, the interest coverage of LIFE SCIENCES HOLDINGS FR... (-12972.7x) ranks in the bottom 25% of the sector. This ratio indicates how many times operating income covers interest expenses. Low coverage may indicate fragility to rate or income variations.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 76 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 6 days. The gap of 70 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Inventory turnover is 1 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 287 days of revenue, i.e. 18.2 M€ to permanently finance. Over 2016-2024, WCR increased by +137%, requiring additional financing.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

18 216 283 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

76 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

6 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

1 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

287 j

WCR and payment terms evolution
LIFE SCIENCES HOLDINGS FRANCE SAS

Positioning of LIFE SCIENCES HOLDINGS FRANCE SAS in its sector

Comparison with sector Réparation de matériels électroniques et optiques

Valuation estimate

Based on 197 transactions of similar company sales (all years), the value of LIFE SCIENCES HOLDINGS FRANCE SAS is estimated at 6 518 351 € (range 3 273 945€ - 11 631 112€). The price/revenue ratio is 0.28x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
197 transactions
3273k€ 6518k€ 11631k€
6 518 351 € Range: 3 273 945€ - 11 631 112€
NAF 4 all-time Aggregated at NAF sub-class level

Valuation method used

Revenue Multiple
22 874 720 € × 0.28x = 6 518 351 €
Range: 3 273 946€ - 11 631 113€

Only this financial indicator is available for this company.

How is this estimate calculated?

This estimate is based on the analysis of 197 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Réparation de matériels électroniques et optiques)

Compare LIFE SCIENCES HOLDINGS FRANCE SAS with other companies in the same sector:

Voir toutes les statistiques du secteur Réparation de matériels électroniques et optiques

Frequently asked questions about LIFE SCIENCES HOLDINGS FRANCE SAS

What is the revenue of LIFE SCIENCES HOLDINGS FRANCE SAS ?

The revenue of LIFE SCIENCES HOLDINGS FRANCE SAS in 2024 is 22.9 M€.

Is LIFE SCIENCES HOLDINGS FRANCE SAS profitable?

LIFE SCIENCES HOLDINGS FRANCE SAS recorded a net loss in 2024.

Where is the headquarters of LIFE SCIENCES HOLDINGS FRANCE SAS ?

The headquarters of LIFE SCIENCES HOLDINGS FRANCE SAS is located in SAINT-GERMAIN-EN-LAYE (78100), in the department Yvelines.

Where to find the tax return of LIFE SCIENCES HOLDINGS FRANCE SAS ?

The tax return of LIFE SCIENCES HOLDINGS FRANCE SAS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does LIFE SCIENCES HOLDINGS FRANCE SAS operate?

LIFE SCIENCES HOLDINGS FRANCE SAS operates in the sector Réparation de matériels électroniques et optiques (NAF code 33.13Z). See the 'Sector positioning' section above to compare the company with its competitors.